Patents Examined by Jyothsan Venkat
-
Patent number: 5686084Abstract: The specification describes water soluble, cationic products useful as hair colorants or for skin care obtained by oxidative polymerization of a 5,6-dihydroxyindole-2-quaternary amides or esters, as well as compositions containing the same, methods of using the same in compositions to color hair or treat skin and intermediates for producing the products.Type: GrantFiled: December 6, 1995Date of Patent: November 11, 1997Assignee: Clairol IncorporatedInventors: Gottfried Wenke, Giuseppe Prota
-
Patent number: 5684038Abstract: A process and pharmaceutical composition for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amide thereof: ##STR1## dissolved or dispersed in a pharmacologically acceptable carrier. In accordance with the process, a preventively or therapeutically effective amount of the composition is topically administered to a human patient, as required; i.e. for prevention the composition is administered to the area of skin susceptible to exposure to antigen and for treatment the composition is administered to the reaction site.Type: GrantFiled: June 28, 1996Date of Patent: November 4, 1997Assignee: Ascent Pharmaceuticals, Inc.Inventors: Emmett Clemente, Robert W. Mendes, Aloysius O. Anaebonam, Mumtaz Ahmed
-
Patent number: 5684037Abstract: A process and pharmaceutical composition for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amide thereof: ##STR1## dissolved or dispersed in a pharmacologically acceptable carrier. In accordance with the process, a preventively or therapeutically effective amount of the composition is topically administered to a human patient, as required; i.e. for prevention the composition is administered to the area of skin susceptible to exposure to antigen and for treatment the composition is administered to the reaction site.Type: GrantFiled: June 28, 1996Date of Patent: November 4, 1997Assignee: Ascent Pharmaceuticals, Inc.Inventors: Emmett Clemente, Robert W. Mendes, Aloysius O. Anaebonam, Mumtaz Ahmed
-
Patent number: 5683705Abstract: Novel sulfhydryl group-containing amides and disulfide group-containing bis-amides useful for treating or preventing an abnormal biological condition or a disease, and/or improving the texture or appearance of the skin, as well as compositions containing amides and bis-amides and methods for their use are described. Such types of abnormal biological conditions or diseases include skin atrophy, i.e., the thinning and/or general degradation of the dermis often characterized by a decrease in collagen and/or elastin as well as decreased number, size and doubling potential of fibroblast cells, and other maladies including, but are not limited to dry skin, severe dry skin, dandruff, acne, keratoses, psoriasis, eczema, skin flakiness, pruritus, age spots, lentigines, melasmas, wrinkles, warts, blemished skin, hyperpigmented skin, hyperkeratotic skin, inflammatory dermatoses, age-related skin changes and skin in need of cleansers.Type: GrantFiled: March 29, 1996Date of Patent: November 4, 1997Assignee: Estee Lauder, Inc.Inventors: Daniel H. Maes, Jules Zecchino, Althea Knight
-
Patent number: 5679360Abstract: The invention relates to the use of a substance P antagonist for the preparation of a pharmaceutical composition, in particular for topical application, for treating lichens, prurigo, pruriginous toxicoderma and severe pruritus of neurogenic origin.Type: GrantFiled: December 19, 1995Date of Patent: October 21, 1997Assignee: L'OrealInventors: Olivier de Lacharriere, Lionel Breton
-
Water-soluble magnesium salts in externally applicable formulations and new combination preparations
Patent number: 5679359Abstract: Water-soluble magnesium salts in preparations for an external application are suitable to weaken UV-induced damages to the skin, especially premature aging of the skin and the formation of skin cancer. The effect is enhanced by a combination with vitamin E and/or vitamin E esters.Type: GrantFiled: January 4, 1996Date of Patent: October 21, 1997Assignee: Wogepharm GmbHInventor: Wolfgang Diezel -
Patent number: 5676955Abstract: This invention relates to a mixture of homologous narrow range lauryl polyglycol ethers, to its use as a local anaesthetic agent.Type: GrantFiled: June 6, 1995Date of Patent: October 14, 1997Assignee: Henkel Kommanditgesellschaft auf AktienInventors: Achim Ansmann, Ansgar Behler, Rolf Franke, Peter Schmersahl
-
Patent number: 5674477Abstract: Mammalian hair growth is reduced by applying to the skin a dermatologically acceptable composition including a catechin compound.Type: GrantFiled: February 28, 1995Date of Patent: October 7, 1997Inventor: Gurpreet S. Ahluwalia
-
Patent number: 5672351Abstract: The present invention relates to anti-microbial cosmetic compositions for the care of the human body or parts thereof, comprising derivatives of histatins or fragments thereof. It has been found that the anti-microbial activity of histatins or their fragments can be significantly enhanced by capping them at the C-terminus or at the C- and N-terminus and/or complexing them with anti-microbially-active metal ions. The thus modified histatins and histatin fragments were found to have a significantly increased activity against a range of microbial strains, and were found to be useful as controlled delivery agents for the metal ions. They are suitable for a whole range of anti-microbial applications, such as anti-plaque, and-caries, anti-bad breath oral applications, deodorant applications, personal hygiene applications and so on, for which they are included in any suitable carrier medium. Preferred are the capped derivatives, which have been complexed with Ag, Cu, Zn or Sn.Type: GrantFiled: December 11, 1995Date of Patent: September 30, 1997Assignee: Chesebrough-Pond's USA Co., Division of Conopco, Inc.Inventors: Michael C. L. Chikindas, Andrew Joiner, Philip William Small
-
Patent number: 5667793Abstract: Anti-cellulite compositions based on a lipolytic active, which is an extract of Polygala tenuifolia, an extract of Platycodon grandiflorum, or an extract of Kochia scoparia. When Polygala tenuifolia or Platycodon grandiflorum is employed, a polar solvent extract is preferred. The extracts are preferably employed in conjunction with a xanthine, e.g. caffeine or theophylline (which are preferably obtained from a natural source), in order to lower the cost of the compositions.Type: GrantFiled: August 2, 1996Date of Patent: September 16, 1997Assignee: Chesebrough-Pond's USA Co., Division of Conopco, Inc.Inventors: Suk Hyung. Cho, Norman Kramer Richardson, Allan Robert Burger, Anita Marie Brinker, Mark Edward Rerek
-
Patent number: 5667792Abstract: A cosmetic or dermatological composition with a depigmenting action comprises derivatives of 2,5-dihydroxyphenylcarboxylic acids, their homologs, and their salts, with the derivatives having the following structural formula: ##STR1## wherein: R.sub.1 represents OR.sub.5, OH, or ##STR2## R.sub.5 is a linear or branched C.sub.1 -C.sub.20 alkyl radical, a linear or branched C.sub.2 -C.sub.20 alkenyl radical, or a C.sub.1 -C.sub.20 alkyl radical substituted by one or more hydroxy or alkoxy groups;r' and r", identical or different, represent a hydrogen atom, a C.sub.1 -C.sub.20 alkyl radical, a C.sub.2 -C.sub.6 hydroxyalkyl radical, or a C.sub.3 -C.sub.6 polyhydroxyalkyl, or r' and r" taken together, with the nitrogen atom, form a heterocycle;the number of carbon atoms in the --(CH.sub.2).sub.n --COR.sub.1 chain is less than or equal to 21;R.sub.2 and R.sub.3, identical or different, represent a hydrogen atom, a linear or branched C.sub.1 -C.sub.4 alkyl radical, or a C.sub.1 -C.sub.4 alkoxy; R.sub.Type: GrantFiled: July 19, 1996Date of Patent: September 16, 1997Assignee: L'OrealInventors: Alex Junino, Alain Lagrange, Quang Lan N'Guyen, Marie-Alix Bourboulon
-
Patent number: 5667772Abstract: The invention relates to preparations for the improved release of oxygen into the skin and to the use of same as cosmetics/dermatics. The preparations according to this invention contain, as the essential component, fluorocarbon emulsions consisting of nonionic emulsifiers and an oxygen-loaded fluorocarbon or fluorocarbon mixture, the fluorocarbon content being in the range from 0.05 to 100% by weight/volume. They are prepared by emulsifying the corresponding components and incorporating the resulting emulsion in known carriers for, for example, ointments, creams, lotions, waters, alcoholic extracts, pastes, powders, gels, tinctures or masks.Type: GrantFiled: May 28, 1996Date of Patent: September 16, 1997Assignee: Lancaster Group AGInventors: Leonhard Zastrow, Klaus Stanzl, Joachim Roding
-
Patent number: 5667789Abstract: The invention relates to the use of a salicylic acid derivative salified with a base, as a stabilizer for an oil-in-water emulsion. This salified derivative has the same properties as its acidic homologue, while at the same time having a less irritating nature. This salified derivative is, in particular, an n-alkanoyl-5-salicylic acid salified with an amphoteric base such as lysine or arginine. The present compositions are more especially intended for the cosmetic and dermatological fields.Type: GrantFiled: November 3, 1995Date of Patent: September 16, 1997Assignee: L'OrealInventors: Nathalie Collin, Eric Quemin, Didier Candau
-
Patent number: 5665377Abstract: The adhesive plaster for the transdermal administration of estradiol or mixture estradiol/progestin is composed of an impermeable carrier film and of an adhesive composition. The latter represents a matrix or reservoir layer and is composed of a solvent-based polyacrylate or polyisobutylene adhesive which contains a saturated or unsaturated fatty acid with 6 to 18 C atoms as permeability enhancer, estradiol or mixture estradiol/progestin as active substance and optionally propylene glycol as solvent.The adhesive plaster is used for the systemic administration of hormones in hormone replacement therapy for a time of at least 3 days.Type: GrantFiled: December 19, 1994Date of Patent: September 9, 1997Assignee: Giapharma SAInventor: Jacques Gonella
-
Patent number: 5665338Abstract: A hair treatment composition comprising (A) a keratin-reducing substance; and (B) a nonionic amphiphatic compound which contains at least one long-chain branched alkyl or alkenyl group per molecule, and which has an HLB of 2-12, the compound itself or a mixture of the compound and water maintaining a liquid crystal structure at a temperature ranging from 0.degree.-50.degree. C. The composition possesses excellent moisturizability, smoothness and softness, exhibits a remarkably high conditioning effect which is sustainable, and exhibits the effects of reducing damage to the hair and preventing the occurrence of split hairs, and imparting gloss to the hair.Type: GrantFiled: October 30, 1995Date of Patent: September 9, 1997Assignee: Kao CorporationInventors: Tadashi Tanimura, Yoshiko Tabata
-
Patent number: 5662920Abstract: A method for smoking cessation therapy is described that utilizing an improved nicotine lozenge to satisfy transient craving. The lozenge contains nicotine, a nonnutritive sweetener and an absorbent excipient.Type: GrantFiled: May 15, 1996Date of Patent: September 2, 1997Assignee: Pharmacia ABInventor: Gian Carlo Santus
-
Patent number: 5660820Abstract: An aqueous cosmetic composition for fixing hair is an aqueous particulate dispersion. The dispersion includes particles of a film-forming polymer containing carboxylic acid functions neutralized to a degree of neutralization from between 10 and 80 percent using a non-volatile monobasic agent. The particles have an average diameter of between 10 and 300 nm. The aqueous dispersion also includes at least one plasticizing agent. The composition may be used as an aerosol lacquer, a fixing or setting lotion or a styling mousse.Type: GrantFiled: June 7, 1995Date of Patent: August 26, 1997Assignee: L'OrealInventors: Jean Mondet, Jean-Michel Sturla, Bertrand Lion, Christine Dupuis, Colette Cazeneuve
-
Patent number: 5658554Abstract: A mouth moistener for alleviating dry mouth condition comprised of an aqueous vehicle containing less than about 2% by weight an edible organic acid such as citric or malic acid and a mixture of a water soluble calcium ion releasing salt and a water soluble phosphate ion releasing salt, wherein the solution is unsaturated with respect to calcium phosphate and the solubility product (S.P.) of the calcium and phosphate ion concentration present in the solution, as expressed by the equationS.P.=[Ca][PO.sub.4 ].sup.2is less than about 0.004, wherein [Ca] is the molar concentration of the released calcium ions and [PO.sub.4 ] is the molar concentration of the released phosphate ion.Type: GrantFiled: June 1, 1995Date of Patent: August 19, 1997Assignee: Colgate-Palmolive CompanyInventors: Steven W. Fisher, Edward A. Tavss, Shannon K. Campbell, Marilou T. Joziak, Karen J. De Pierro, John P. Curtis
-
Patent number: 5656255Abstract: A composition for administration to the nasal mucosa of a subject comprises a solution of nicotine or a pharmaceutically acceptable salt thereof in a pharmaceutically acceptable solvent. The composition has a nicotine concentration in the range of about 10 to about 40 mg/ml and contains a suitable agent to produce a viscosity in the range of about 1 to about 30 centipoise. The composition assists in reduction of the desire of the subject to smoke tobacco or provides a substitute for tobacco smoking.Type: GrantFiled: September 29, 1994Date of Patent: August 12, 1997Assignee: Pharmacia & Upjohn ABInventor: Richard L. Jones
-
Patent number: 5643581Abstract: New cosmetic compositions characterized in that they comprise, in a cosmetically acceptable carrier, at least one pseudolatex based on a multiblock polycondensate which contains a polysiloxane block and a polyurethane and/or polyurea block, wherein the polyurethane and/or polyurea block further comprises anionic or cationic groups. These compositions can be employed especially in the cosmetic field of hair care, of make-up or of skin care.Type: GrantFiled: July 27, 1994Date of Patent: July 1, 1997Assignee: L'OrealInventors: Nathalie Mougin, Jean Mondet